https://doi.org/10.1016/j.ymthe.2020.12.026
D
David Boczkowski
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
6.0K
Citations
35
h-index
44
i10-index
David Boczkowski is an academic researcher. The author has contributed to research in topics: Immunotherapy and Immune Responses & RNA Interference and Gene Delivery & Cancer Immunotherapy and Biomarkers. The author has an h-index of 35, co-authored 88 publications.
Papers by this author
worksControlling cancer-induced inflammation with a nucleic acid scavenger prevents lung metastasis in murine models of breast cancer
2020 · Molecular Therapy · 26 citations
High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopes
2014 · Scientific Reports · 8 citations
https://doi.org/10.1038/srep04632
Figure S3 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727851
Figure S5 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727842
Figure S4 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727848
Figure S6 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727839
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat